RapidArc Treats First UK Patient, Targets Prostate Cancer

December 10, 2008 – A prostate cancer patient from Warrington in Cheshire, UK, becomes first in his country to be treated using RapidArc Radiotherapy from Varian Medical Systems.

The 65-year-old cancer patient was diagnosed with prostate cancer in June, and reportedly has had his treatment slot reduced by 25 percent due to the introduction of RapidArc, with even greater savings in 'beam-on' time.

With RapidArc, Varian’s Clinac medical linear accelerator can target radiation beams at a tumor while making one continuous rotation around the patient. RapidArc delivers a volumetric intensity-modulated radiation therapy treatment in a single or multiple arcs of the treatment machine around the patient and makes it possible to deliver advanced image-guided IMRT two to eight times faster than is possible with conventional IMRT.

According to Angela Heaton, the 'beam-on' time for the patient was reduced from nearly four minutes with conventional IMRT to just one minute 10 seconds with RapidArc. The total time he spent in the treatment room was reduced from over 10 minutes to eight and a half minutes. In addition, the RapidArc prostate plan resulted in a better dose distribution and avoidance of organs at risk, she said. "Shortly we intend to start using RapidArc for complex head and neck cancer treatments and we expect the beam-on time will be reduced from 25 minutes using IMRT to about two and a half minutes using two arcs with RapidArc, resulting in more efficient treatments and potentially shortening waiting lists," said Angela Heaton, research radiographer at Clatterbridge Centre for Oncology, where the patient was treated.

RapidArc technology allows more control to conform the dose more closely to the size, shape, and location of the tumor. Faster treatment also contributes to precision by reducing the time for motion within the anatomy, and laboratory studies suggest that faster dose delivery may kill some cancer cells more effectively.

For more information:

Related Content

PTW announces first North American installation and FDA 510(k) clearance of Beamscan MR motorized 3-D water phantom

PTW Beamscan MR for Elekta Unity

News | Radiation Oncology | April 17, 2020
April 17, 2020 — PTW has installed the first Beamscan MR motor...
Elekta Unity MR Linac system
News | Radiation Oncology | January 30, 2020
January 30, 2020 — Elekta announced that it signed a contract wit
IBA Dosimetry Releases myQA Machines Software at ASTRO 2019
Technology | Quality Assurance (QA) | September 12, 2019
IBA Dosimetry GmbH announced the launch of the new enhanced myQA Machines 2019 software environment at the upcoming...
Gustave Roussy, Elekta, Versa HD, linear accelerators, Mosaiq, France

Image courtesy of Elekta

News | Radiation Therapy | September 04, 2015
Gustave Roussy has awarded Elekta with an order for four Versa HD linear accelerators, replacing their existing...
ECRI Institute, linear accelerators, linac, purchase, survey
News | June 23, 2015
The ECRI Institute released a new techIQ brief on key factors to consider when purchasing a linear accelerator (linac)...
Brainlab, Exactrac, Elekta, Versa HD, LMU Medical Center, Munich
News | June 23, 2015
Brainlab announced first patient treatments in March on a fully integrated radiation oncology solution that combines...
Elekta, William Beaumont Hospital, patent lawsuit, Varian, linear accelerator
News | June 19, 2015
On June 16, 2015, William Beaumont Hospital and Elekta Ltd. filed a patent infringement suit against Varian Medical...
Brainlab, ExacTrac, Versa HD, Elekta, LMU, Munich, LINAC, first
Feature | March 24, 2015
Brainlab announced first patient treatments on a fully integrated radiation oncology solution that combines ExacTrac...
News | September 02, 2014
September 2, 2014 — In an agreement signed in Tokyo, Elekta Japan will grant Toshiba Medical Systems Corp. (TMSC) wider...